CD4 and neoplasm: These data confirm that antigen-specific CD4 T cells induced by vaccination with ITI-3000 are sufficient to delay tumor progression in the B16-LT model and also identify IFNγ as the key factor involved in this CD4 T cell-mediated mechanism.